Gastrointestinal protectants and cathartics

Veterinary Clinics of North America - Equine Practice

Volumn 19, Issue 3, 2003, Pages 599-615

  Tillotson, Kirsten ^a   Traub Dargatz, Josie L ^b  

^a 387 Pine Knoll Acres   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BISMUTH SALICYLATE; BUTYRIC ACID; CASTOR OIL; DOCUSATE SODIUM; EPIC; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; GLUTAMINE; ISPAGULA; KAOLIN; LAXATIVE; LINSEED OIL; MAGNESIUM SULFATE; METRONIDAZOLE; MINERAL OIL; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PECTIN; PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; SILICON DIOXIDE; SODIUM SULFATE; SUCRALFATE; GASTROINTESTINAL AGENT;

ABORTION; ANOREXIA; BACTERIAL INFECTION; BARLEY; BRAN; CLOSTRIDIUM DIFFICILE; COLIC; COLITIS; COLLAPSE; COLON DISEASE; COLON FLORA; COLON ULCER; DEHYDRATION; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM INFLAMMATION; DISORDERS OF ACID BASE BALANCE; DRUG SAFETY; ENDOTOXEMIA; ENTERITIS; ENTEROCOCCUS; ESOPHAGUS OBSTRUCTION; ESSENTIAL FATTY ACID DEFICIENCY; FLACCID PARALYSIS; FLUID THERAPY; GASTROINTESTINAL DISEASE; HUMAN; HYPERMAGNESEMIA; INTESTINE CELL; INTESTINE OBSTRUCTION; MUSCLE CRAMP; NONHUMAN; REVIEW; SACCHAROMYCES CEREVISIAE; STOMACH DISTENSION; STOMACH ULCER; ULCERATIVE COLITIS; ANIMAL; ANIMAL DISEASE; COLON; DIGESTIVE FUNCTION; HORSE; HORSE DISEASE; INTESTINE ABSORPTION; MICROBIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); CASTOR; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; ENTEROCOCCUS; EQUUS CABALLUS; HORDEUM VULGARE SUBSP. VULGARE; PLANTAGO OVATA; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

ANIMALS; CATHARTICS; COLON; DIGESTIVE PHYSIOLOGY; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HORSE DISEASES; HORSES; INTESTINAL ABSORPTION; INTESTINAL OBSTRUCTION; TREATMENT OUTCOME;

EID: 1842592082     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2003.08.008     Document Type: Review

References (61)

1. Moffatt R.E., Kramer L.L., Lerner D., Jones R. Studies on dioctyl sodium sulfosuccinate toxicity: clinical, gross and microscopic pathology in the horse and guinea pig. Can J Comp Med. 39:(4):1975;434-441
2. Bertone J.J., Traub-Dargatz J.L., Wrigley R.W., Bennett D.G., Williams R.J. Diarrhea associated with sand in the gastrointestinal tract of horses. J Am Vet Med Assoc. 193:(11):1988;1409-1412
3. Ruggles A.J., Ross M.W. Medical and surgical management of small-colon impaction in horses: 28 cases (1984-1989). J Am Vet Med Assoc. 199:(12):1991;1762-1766
4. Freeman D.E., Ferrante P.L., Palmer J.E. Comparison of the effects of intragastric infusions of equal volumes of water, dioctyl sodium sulfosuccinate, and magnesium sulfate on fecal composition and output in clinically normal horses. Am J Vet Res. 53:(8):1992;1347-1353
5. Johnson C.M., Cullen J.M., Roberts M.C. Morphologic characterization of castor oil-induced colitis in ponies. Vet Pathol. 30:(3):1993;248-255
6. Hanson R.R., Schumacher J., Humburg J., Dunkerley S.C. Medical treatment of horses with ileal impactions: 10 cases (1990-1994). J Am Vet Med Assoc. 208:(6):1996;898-900
7. White N.A. II, Dabareiner R.M. Treatment of impaction colics. Vet Clin North Am Equine Pract. 13:(2):1997;243-259
8. Hammock P.D., Freeman D.E., Baker G.J. Failure of psyllium mucilloid to hasten evacuation of sand from the equine large intestine. Vet Surg. 27:(6):1998;547-554
9. Rhoads W.S., Barton M.H., Parks A.H. Comparison of medical and surgical treatment for impactions of the small colon in horses: 84 cases (1986-1996). J Am Vet Med Assoc. 214:(7):1999;1042-1047
10. Ruohoniemi M., Kaikkonen R., Raekallio M., Luukkanen L. Abdominal radiography in monitoring the resolution of sand accumulations from the large colon of horses treated medically. Equine Vet J. 33:(1):2001;59-64
11. Schumacher J., DeGraves F.J., Spano J.S. Clinical and clinicopathologic effects of large doses of raw linseed oil as compared to mineral oil in healthy horses. J Vet Intern Med. 11:(5):1997;296-299
12. Henninger R.W., Horst J. Magnesium toxicosis in two horses. J Am Vet Med Assoc. 211:(1):1997;82-85
13. Hintz H.F. Digestive physiology of the horse. J S Afr Vet Assoc. 46:(1):1975;13-17
14. Lopes MF, Moura GS, Filho JD. Treatment of large colon impaction with enteral fluid therapy. In: Proceedings of the 48th Annual Convention of the American Association of Equine Practitioners. Albuquerque; 1999. p. 99-102.
15. Lopes M.F., Walker B.L., White N.A., Ward D.L. Treatments to promote colonic hydration: enteral fluid therapy versus intravenous fluid therapy and magnesium sulfate. Equine Vet J. 34:2002;505-509
16. Lopes M.F. Physiological aspects, indications and contraindications of enteral fluid therapy. Equine Vet Educ. 4:(5):2002;330-336
17. Schott J.C. Oral fluids for equine diarrhoea: an underutilized treatment for a costly disease? Vet J. 155:1998;119-121
18. Ecke P., Hodgson D.R., Rose R.J. Induced diarrhoea in horses Part 1: fluid and electrolyte balance. Vet J. 155:(2):1998;149-159
19. Ecke P., Hodgson D.R., Rose R.J. Induced diarrhoea in horses Part 2: response to administration of an oral rehydration solution. Vet J. 155:(2):1998;161-170
20. Weese J.S. Microbiologic evaluation of commercial probiotics. J Am Vet Med Assoc. 220:(6):2002;794-797
21. Weese JS. A review of probiotics: are they really "functional foods?" In: Proceedings of the 47th Annual Convention of the American Association of Equine Practitioners. San Diego; 2001. p. 27-31.
22. Canganella F., Paganini S., Ovidi M., Vettraino A.M., Bevilacqua L., Massa S., et al. A microbiological investigation on probiotic pharmaceutical products used for human health. Microbiol Res. 152:(2):1997;171-179
23. Sanders M.E. Development of consumer probiotics for the US market. Br J Nutr. 80:(Suppl 2):1998;S213-S218
24. Madsen K.L. The use of probiotics in gastrointestinal disease. Can J Gastroenterol. 15:(12):2001;817-822
25. Bleichner G., Blehaut H., Mentec H., Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. Intensive Care Med. 23:1997;517-523
26. Kailasapathy K., Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol. 78:(1):2000;80-88
27. Thomas M.R., Litin S.C., Osmon D.R., Corr A.P., Weaver A.L., Lohse C.M. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc. 76:(9):2001;883-889
28. Izadnia F., Wong C.T., Kocoshis S.A. Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat. Dig Dis Sci. 43:(9):1998;2055-2060
29. Parraga M.E., Spier S.J., Thurmond M., Hirsh D. A clinical trial of probiotic administration for prevention of Salmonella shedding in the post-operative period in horses with colic. J Vet Intern Med. 11:(1):1997;36-41
30. Hickman M.A. Interventional nutrition for gastrointestinal disease. Clin Tech Small Anim Pract. 13:(4):1998;211-216
31. Hayden U.L., McGuirk S.M., West S.E., Carey H.V. Psyllium improves fecal consistency and prevents enhanced secretory responses in jejunal tissues of piglets infected with ETEC. Dig Dis Sci. 43:(11):1998;2536-2541
32. Morita T., Kasaoka S., Hase K., Kiriyama S. Psyllium shifts the fermentation site of high-amylose cornstarch toward the distal colon and increases fecal butyrate concentration in rats. J Nutr. 129:(11):1999;2081-2087
33. Kanauchi O., Iwanaga T., Mitsuyama K. Germinated barley foodstuff feeding. A novel neutraceutical therapeutic strategy for ulcerative colitis. Digestion. 63:(Suppl 1):2001;60-67
34. Fukuda M., Kanauchi O., Araki Y., Andoh A., Mitsuyama K., Takagi K., et al. Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. Int J Mol Med. 9:(1):2002;65-70
35. Bamba T., Kanauchi O., Andoh A., Fujiyama Y. A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis. J Gastroenterol Hepatol. 17:(8):2002;818-824
36. Kanauchi O., Mitsuyama K., Saiki T., Nakamura T., Hitomi Y., Bamba T., et al. Germinated barley foodstuff increases fecal volume and butyrate production at relatively low doses and relieves constipation in humans. Int J Mol Med. 2:(4):1998;445-450
37. Plumb D.C. Veterinary drug handbook. 2nd edition:1995;Iowa State University Press, Ames. 84-5
38. Weese JS, Cote NM, deGrannes RVG. Evaluation of the ability of Di-tri-octahedral smectite to adhere to Clostridium difficile toxins and Clostridium perfringens enterotoxin in vitro. In: Proceedings of the 48th Annual Convention of the American Association of Equine Practitioners. Orlando; 2002. p. 127-30.
39. Rateau J.G., Morgant G., Droy-Priot M.T., Parier J.L. A histological, enzymatic and water-electrolyte study of the action of smectite, a mucoprotective clay, on experimental infectious diarrhoea in the rabbit. Curr Med Res Opin. 8:1982;224-241
40. Mahraui L., Heyman M., Plique O., Droy-Lefaix M.T., Desjeux J.F. Apical effect of diosmectite on damage to the intestinal barrier induced by tumor necrosis factor-α Gut. 40:1997;339-343
41. Albengres E., Urien S., Tillemen J.P., Oury P., Decourt S., Flouvat B., et al. Interactions between smectite, a mucus stabilizer, and acidic and basic drugs. Eur J Clin Pharmacol. 28:(5):1985;601-605
42. Madkour A.A., Madina E.M.H., El-Azzouni O.E.Z., Amer M.A., El-Walili T.M.K., Abbass T. Smectite in acute diarrhea in children: a double blind placebo-controlled clinical trial. J Pediatr Gastroenterol Nutr. 17:1993;176-181
43. Herthel D. Preventing and treating colitis with DTO smectite. J Equine Vet Sci. 20:(7):2000;432
44. Weese J.S., Staempfli H.R., Prescott J.F. A prospective study of the roles of Clostridium difficile and enterogenic Clostridium perfringens in equine diarrhoea. Equine Vet J. 33:2001;403-409
45. Velazquez M., Davies C., Marett R., Slavin J.L., Feirtag J. Effect of oligosaccharides and fibre substitutes on short-chain fatty acid production by human faecal microflora. Anaerobe. 6:2000;87-92
46. Inan M.S., Rasoulpour R.J., Yin L., Hubbard A.K., Rosenberg D.W., Giardina C. The luminal short-chain fatty acid butyrate modulates NF-κB activity in a human colonic epithelial cell line. Gastroenterology. 118:2000;724-734
47. Kanauchi O., Andoh A., Iwanaga T., Fujiyama Y., Mitsuyama K., Toyonaga A. Ileitis, colitis and nutrients. Germinated barley foodstuffs attenuate colonic mucosal damage and mucosal nuclear factor kappa B activity in a spontaneous colitis model. J Gastroenterol Hepatol. 14:1999;1173-1179
48. Yin L., Laevsky G., Giardina C. Butyrate suppression of colonocyte NF-κB activation and cellular proteasome activity. J Biol Chem. 276:(48):2001;44641-44646
49. McCann M.E., Carrick J.B. Potential uses of ω-3 fatty acids in equine diseases. Compend Contin Educ Pract Vet. 20:1998;637-641
50. Bower R.H., Cerra F.B., Bershadsky B., Licari J.J., Hoyt D.B., Jensen G.L., et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med. 23:(3):1995;436-449
51. Hansen R.A., Savage C.J., Reidlinger K., Traub-Dargatz J.L., Ogilvie G.K., Mitchell D., et al. Effects of dietary flaxseed oil supplementation on equine plasma fatty acid concentrations and whole blood platelet aggregation. J Vet Intern Med. 16:(4):2002;457-463
52. McCann M.E., Moore J.N., Carrick J.B., Barton M.H. Effect of intravenous infusion of omega-3 and omega-6 lipid emulsions on equine monocyte fatty acid composition and inflammatory mediator production in vitro. Shock. 14:(2):2000;222-228
53. Sokol R.J., Hoffenberg E.J. Antioxidants in pediatric gastrointestinal disease. Pediatr Clin North Am. 43:(2):1996;471-488
54. Sangiah S., MacAllister C.C., Amouzadeh H.R. Effects of misoprostol and omeprazole on basal gastric pH and free acid content in horses. Res Vet Sci. 47:(3):1989;350-354
55. Takahashi S., Okabe S. Stimulatory effects of sucralfate on secretion and synthesis of mucus by rabbit gastric mucosal cells. Involvement of phospholipase, C. Dig Dis Sci. 41:(3):1996;498-504
56. Rostom A., Dube C., Wells G., Tugwell P., Welch V., Jolicoeur E., et al. Prevention of NSAID-induced gastroduodenal ulcers. [abstract] Cochrane Database Syst Rev. 4:2002;CD002296
57. Madsen F.C., Stout R.C. Egg protein in complexes for neonatal foal diarrhea. J Equine Vet Sci. 20:(3):2002;158-160
58. Bennett-Steward K. Neonatal foals and hyperimmunized egg protein - a viable therapy for newborn foals? J Equine Vet Sci. 22:(3):2002;105-107
59. Otake S., Nishihara Y., Makimura M., Hatta H., Kim M., Yamamoto T., et al. Protection of rats against dental caries by passive immunization with hen-egg-yolk antibody (IgY). J Dent Res. 70:(3):1991;162-166
60. Marquardt R.R., Jin L.Z., Kim J.W., Fang L., Frohlich A.A., Baidoo S.K. Passive protective effect of egg-yolk antibodies against enterotoxigenic Escherichia coli K88+ infection in neonatal and early-weaned piglets. FEMS Immunol Med Microbiol. 23:(4):1999;283-288
61. Ehrard M.H., Kellner J., Eichelberger J., Losch U. New possibilities in oral immunoprophylaxis of newborn diarrhea in calves - a field study using specific egg antibodies. [abstract] Berl Munch Tierarztl Wochenschr. 106:(11):1993;383-387